The Vancouver Prostate Centre is a prostate cancer translational research centre located in Vancouver, British Columbia. It is a UBC and VGH Centre of Excellence and a designated national Centre of Excellence for Commercialization and Research.

During the past decade, Vancouver Prostate Centre conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vancouver Prostate Centre" #1 sponsor was "NCIC Clinical Trials Group" with 4 trials, followed by "Vancouver Prostate Centre" with 4 trials sponsored, "Pfizer" with 3 trials sponsored, "Canadian Urology Research Consortium" with 2 trials sponsored and "Lawson Health Research Institute" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vancouver Prostate Centre" #1 collaborator was "NCIC Clinical Trials Group" with 5 trials as a collaborator, "Astellas Pharma Inc" with 3 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator and "Prostate Cancer Canada" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Vancouver Prostate Centre" are "Prostate Cancer" (12 trials), "Benign Prostatic Hyperplasia" (2 trials), "Bladder Cancer" (2 trials), "Cancer of the Prostate" (2 trials) and "Ovarian Cancer" (2 trials). Many other conditions were trialed in "Vancouver Prostate Centre" in a lesser frequency.

Most popular intervention types in "Vancouver Prostate Centre" are "Drug" (17 trials), "Other" (3 trials), "Procedure" (3 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Enzalutamide" (4 trials), "Placebo" (4 trials), "Leuprolide" (2 trials), "alvocidib" (2 trials) and "gemcitabine hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "Vancouver Prostate Centre" are 16 trials for "Male" genders, 8 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Vancouver Prostate Centre". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Vancouver Prostate Centre, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Vancouver Prostate Centre, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".